Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
- PMID: 23796131
- PMCID: PMC3791615
- DOI: 10.1056/NEJMoa1212914
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
Erratum in
- N Engl J Med. 2014 May 8;370(19):1866
Abstract
Background: Weight loss is recommended for overweight or obese patients with type 2 diabetes on the basis of short-term studies, but long-term effects on cardiovascular disease remain unknown. We examined whether an intensive lifestyle intervention for weight loss would decrease cardiovascular morbidity and mortality among such patients.
Methods: In 16 study centers in the United States, we randomly assigned 5145 overweight or obese patients with type 2 diabetes to participate in an intensive lifestyle intervention that promoted weight loss through decreased caloric intake and increased physical activity (intervention group) or to receive diabetes support and education (control group). The primary outcome was a composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina during a maximum follow-up of 13.5 years.
Results: The trial was stopped early on the basis of a futility analysis when the median follow-up was 9.6 years. Weight loss was greater in the intervention group than in the control group throughout the study (8.6% vs. 0.7% at 1 year; 6.0% vs. 3.5% at study end). The intensive lifestyle intervention also produced greater reductions in glycated hemoglobin and greater initial improvements in fitness and all cardiovascular risk factors, except for low-density-lipoprotein cholesterol levels. The primary outcome occurred in 403 patients in the intervention group and in 418 in the control group (1.83 and 1.92 events per 100 person-years, respectively; hazard ratio in the intervention group, 0.95; 95% confidence interval, 0.83 to 1.09; P=0.51).
Conclusions: An intensive lifestyle intervention focusing on weight loss did not reduce the rate of cardiovascular events in overweight or obese adults with type 2 diabetes. (Funded by the National Institutes of Health and others; Look AHEAD ClinicalTrials.gov number, NCT00017953.).
Figures
Comment in
-
Do lifestyle changes reduce serious outcomes in diabetes?N Engl J Med. 2013 Jul 11;369(2):189-90. doi: 10.1056/NEJMe1306987. Epub 2013 Jun 24. N Engl J Med. 2013. PMID: 23796132 No abstract available.
-
Diabetes: Look AHEAD published: weight loss not linked to fewer cardiovascular events in patients with type 2 diabetes.Nat Rev Cardiol. 2013 Aug;10(8):429. doi: 10.1038/nrcardio.2013.101. Epub 2013 Jul 9. Nat Rev Cardiol. 2013. PMID: 23836280 No abstract available.
-
Modest weight loss does not decrease cardiovascular morbidity and mortality in adults with type 2 diabetes.Evid Based Med. 2014 Apr;19(2):64. doi: 10.1136/eb-2013-101518. Epub 2013 Oct 10. Evid Based Med. 2014. PMID: 24113231 No abstract available.
-
ACP Journal Club. A lifestyle intervention did not reduce cardiovascular outcomes in overweight or obese patients with type 2 diabetes.Ann Intern Med. 2013 Oct 15;159(8):JC4. doi: 10.7326/0003-4819-159-8-201310150-02004. Ann Intern Med. 2013. PMID: 24126665 No abstract available.
-
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013 Dec 12;369(24):2358-9. doi: 10.1056/NEJMc1312802. N Engl J Med. 2013. PMID: 24328474 No abstract available.
-
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013 Dec 12;369(24):2356. doi: 10.1056/NEJMc1312802. N Engl J Med. 2013. PMID: 24328475 No abstract available.
-
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013 Dec 12;369(24):2356. doi: 10.1056/NEJMc1312802. N Engl J Med. 2013. PMID: 24328476 No abstract available.
-
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013 Dec 12;369(24):2356-7. doi: 10.1056/NEJMc1312802. N Engl J Med. 2013. PMID: 24328477 No abstract available.
-
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013 Dec 12;369(24):2357. doi: 10.1056/NEJMc1312802. N Engl J Med. 2013. PMID: 24328478 No abstract available.
-
Intensive lifestyle intervention in type 2 diabetes.N Engl J Med. 2013 Dec 12;369(24):2357-8. doi: 10.1056/NEJMc1312802. N Engl J Med. 2013. PMID: 24328479 No abstract available.
-
Intensive lifestyle intervention has little effect on cardiovascular complications in people with type 2 diabetes.J R Coll Physicians Edinb. 2013;43(4):315. doi: 10.4997/JRCPE.2013.409. J R Coll Physicians Edinb. 2013. PMID: 24350314 No abstract available.
-
[Cardiovascular effects of an intensive intervention on lifestyle in type 2 diabetes].Rev Clin Esp (Barc). 2014 Mar;214(2):102. doi: 10.1016/j.rce.2013.09.003. Rev Clin Esp (Barc). 2014. PMID: 24772473 Spanish. No abstract available.
-
[Cardiovascular effects of a lifestyle intervention in type 2 diabetes. The Look AHEAD (Action for Health in Diabetes) study].Internist (Berl). 2014 Jun;55(6):735-8. doi: 10.1007/s00108-014-3513-y. Internist (Berl). 2014. PMID: 24817540 German. No abstract available.
Similar articles
-
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.Lancet Diabetes Endocrinol. 2016 Nov;4(11):913-921. doi: 10.1016/S2213-8587(16)30162-0. Epub 2016 Aug 30. Lancet Diabetes Endocrinol. 2016. PMID: 27595918 Free PMC article. Clinical Trial.
-
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.Arch Intern Med. 2010 Sep 27;170(17):1566-75. doi: 10.1001/archinternmed.2010.334. Arch Intern Med. 2010. PMID: 20876408 Free PMC article. Clinical Trial.
-
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.Lancet Diabetes Endocrinol. 2014 Oct;2(10):801-9. doi: 10.1016/S2213-8587(14)70156-1. Epub 2014 Aug 10. Lancet Diabetes Endocrinol. 2014. PMID: 25127483 Free PMC article. Clinical Trial.
-
Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.J Acad Nutr Diet. 2015 Sep;115(9):1447-63. doi: 10.1016/j.jand.2015.02.031. Epub 2015 Apr 29. J Acad Nutr Diet. 2015. PMID: 25935570 Review.
-
The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):69-75. doi: 10.1016/j.pcad.2015.04.002. Epub 2015 Apr 30. Prog Cardiovasc Dis. 2015. PMID: 25936906 Free PMC article. Review.
Cited by
-
Effects of weight loss from oral semaglutide administration on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a retrospective analysis using propensity score matching.Diabetol Int. 2024 Jul 31;15(4):794-805. doi: 10.1007/s13340-024-00744-3. eCollection 2024 Oct. Diabetol Int. 2024. PMID: 39469553
-
The Outcomes of Adult Acquired Buried Penis Surgical Reconstruction.Life (Basel). 2024 Oct 17;14(10):1321. doi: 10.3390/life14101321. Life (Basel). 2024. PMID: 39459621 Free PMC article.
-
[Role of the Pharmacotherapeutic Monitoring Service (PMS) of the Community Pharmacy in the detection and resolution of adverse reactions to statins linked to possible diagnostic errors in elderly patients].Farm Comunitarios. 2024 Sep 17;16(4):5-14. doi: 10.33620/FC.2173-9218.(2024).21. eCollection 2024 Oct 15. Farm Comunitarios. 2024. PMID: 39439866 Free PMC article. Spanish.
-
Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.Open Heart. 2024 Oct 15;11(2):e002704. doi: 10.1136/openhrt-2024-002704. Open Heart. 2024. PMID: 39414309 Free PMC article.
-
The association of ideal cardiovascular health and its change with subclinical atherosclerosis according to glucose status: A prospective cohort study.J Diabetes. 2024 Oct;16(10):e70007. doi: 10.1111/1753-0407.70007. J Diabetes. 2024. PMID: 39387213 Free PMC article.
References
-
- American Diabetes Association . Clinical Practice Recommendations. American Diabetes Association; Alexandria, VA: 2013.
-
- NHLBI Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. Obes Res. 1998;6(S2):51S–210S. - PubMed
-
- Williamson DF. Weight loss and mortality in persons with type-2 diabetes mellitus: A review of the epidemiological evidence. Exp Clin Endocrinol Diabetes. 1998;106(Suppl 2):14–21. - PubMed
-
- Harrington M, Gibson S, Cottrell RC. A review and meta-analysis of the effect of weight loss on all-cause mortality risk. Nurt Res Rev. 2009;22(1):93–108. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- DK57078/DK/NIDDK NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- DK57151/DK/NIDDK NIH HHS/United States
- U01 DK057136/DK/NIDDK NIH HHS/United States
- M01RR000056/RR/NCRR NIH HHS/United States
- DK56990/DK/NIDDK NIH HHS/United States
- DK57135/DK/NIDDK NIH HHS/United States
- UL1 RR 024153/RR/NCRR NIH HHS/United States
- DK57171/DK/NIDDK NIH HHS/United States
- DK57131/DK/NIDDK NIH HHS/United States
- DK57149/DK/NIDDK NIH HHS/United States
- U01 DK056992/DK/NIDDK NIH HHS/United States
- P30 DK079637/DK/NIDDK NIH HHS/United States
- M01RR01066/RR/NCRR NIH HHS/United States
- DK57182/DK/NIDDK NIH HHS/United States
- DK57002/DK/NIDDK NIH HHS/United States
- M01RR01346/RR/NCRR NIH HHS/United States
- DK57178/DK/NIDDK NIH HHS/United States
- P30 DK48520/DK/NIDDK NIH HHS/United States
- DK57008/DK/NIDDK NIH HHS/United States
- K23 HL109235/HL/NHLBI NIH HHS/United States
- U01 DK057131/DK/NIDDK NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- DK57136/DK/NIDDK NIH HHS/United States
- DK57154/DK/NIDDK NIH HHS/United States
- DK57219/DK/NIDDK NIH HHS/United States
- DK57177/DK/NIDDK NIH HHS/United States
- M01RR0021140/RR/NCRR NIH HHS/United States
- DK 046204/DK/NIDDK NIH HHS/United States
- U01 DK057149/DK/NIDDK NIH HHS/United States
- M01RR02719/RR/NCRR NIH HHS/United States
- DK56992/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
- M01RR00051/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical